CB Put Option Terms Amended
HLB테라퓨틱스
115450
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2767
Risk-adjusted indicator based on 2767 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Original Filing Date: November 15, 2024
- • 1st Put Option Yield (Amended): 101.5188%
- • 2nd Put Option Yield (Amended): 101.8046%
- • 6th Put Option Yield (Amended): 102.8197%
- • Put Option Exercise Period: From 18 months after issuance date
AI Analysis Summary
HLB Therapeutics Co.,Ltd. filed an amendment to its Material Fact Report regarding the decision on issuing convertible bonds. The amendment primarily concerns changes to the put option terms, specifically adjusting the early redemption payment date for the 2nd put option from August 20, 2026, to August 31, 2026, and consequently updating the 2nd put option yield from 101.7716% to 101.8046%. Other put option yields remain unchanged, ranging from 101.5188% (1st) to 102.8197% (6th). The core details of the convertible bond issuance, such as total amount, conversion price, and number of shares, are not provided in this amendment, indicating a minor adjustment to existing terms rather than a new issuance or significant change in dilution potential. The impact is neutral as it's a minor adjustment to existing terms.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.